A novel injectable BRET-based in vivo imaging probe for detecting the activity of hypoxia-inducible factor regulated by the ubiquitin-proteasome system
Open Access
- 4 October 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , srep34311
Abstract
The ubiquitin-proteasome system (UPS) is a selective protein degradation system that plays a critical role in many essential biological processes by regulating the existence of various cellular proteins. The target proteins of UPS are recognized and tagged with polyubiquitin chains by E3 ubiquitin ligases, which have high substrate-specific activities. Here we present a novel injectable imaging probe POL-N that can detect the UPS-regulated hypoxia-inducible factor (HIF) activity in vivo. Because the luciferase is fused to the E3 ligase-recognition domain of the HIF-1α, POL-N is intact only in the HIFα-overexpressing cells, that is, HIF-active cells, generating signals via an intramolecular bioluminescence resonance energy transfer (BRET) between luciferase and a near-infrared (NIR) fluorescent dye at the C-terminal end of the probe. Off-target signals of the NIR-BRET were so low that we could achieve highly sensitive and fast detection of intratumoral HIF-activity. Notably, we successfully detected hypoxic liver metastasis, which is extremely difficult to detect by injectable imaging probes due to strong off-target signals, as early as 1 h after systemic injection of POL-N. Our probe design can be widely adapted to UPS-target proteins and may contribute to the exploration of their roles in animal disease models.Keywords
This publication has 32 references indexed in Scilit:
- A transgenic mouse model for monitoring oxidative stressScientific Reports, 2012
- Self-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imagingNature Communications, 2012
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionNature Reviews Cancer, 2011
- Detection of the Onset of Ischemia and Carcinogenesis by Hypoxia-Inducible Transcription Factor-Based In Vivo Bioluminescence ImagingPLOS ONE, 2011
- Bioluminescence resonance energy transfer (BRET) imaging of protein–protein interactions within deep tissues of living subjectsProceedings of the National Academy of Sciences, 2011
- Self‐illuminating in vivo lymphatic imaging using a bioluminescence resonance energy transfer quantum dot nano‐particleContrast Media & Molecular Imaging, 2011
- In Vivo Imaging of HIF-Active Tumors by an Oxygen-Dependent Degradation Protein Probe with an Interchangeable Labeling SystemPLOS ONE, 2010
- Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challengesTrends in Molecular Medicine, 2010
- In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dyeProceedings of the National Academy of Sciences, 2009
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle ProgressionCell, 2008